INSPIRE IVF Public Company LimitedSET: IVF🇹🇭 TH

Risk Management · 2024

Risk Management Policy & Plan

Policy & Plan Description

In today's rapidly changing world situation, The company is aware of the importance of risk management. It is part of promoting good corporate governance. The company therefore gives importance to various internal departments. We have arranged for comprehensive risk management related to the company. By creating a risk management policy and manual to be used as a guideline in risk management, the company's board of directors, executives, and all employees are risk owners (Risk Owners) and are responsible for studying, analyzing, and evaluating opportunities and risk levels. The severity of the impact may have a negative impact on the company's strategy, goals, and objectives and establish measures to limit, prevent and control those risks. And evaluate the efficiency of risk management. Follow up on the situation and factors of risk that may change over time To report to the risk committee audit board and the Company's Board of Directors acknowledges The company arranges for a review of the risk management policy and manual at least once a year.

The Risk Management Committee will consider and determine a risk management policy that covers both internal and external aspects. Including being consistent with the strategy and direction of business operations. It covers at least 7 areas of risk: (1) Strategic risk (Strategic risk) (2) Operational risk (Operational risk) (3) Financial risk (4) Risk. Policy and compliance risk (5) Image and reputation risk (6) Safety risk from danger and disaster (Hazard and disaster risk) (7)other risks

Risks to the Company's Business Operations

Risk Register

Risk NameRisk CharacteristicsConsequencesManagement MeasuresRelated Risk Factors
The risk of relying on coordinators/advisors.

The company connects with customers through coordinators/referrals to introduce the company's services to target customers in various countries, mostly foreigners such as India and the People's Republic of China. As Thailand is renowned for its quality of service and reasonable service fees compared to other countries, Thailand is considered a destination for foreigners seeking infertility treatment. Moreover, the company has been conducting marketing activities abroad before the COVID-19 situation and has continued online marketing during the COVID-19 situation. As a result, the company has gained recognition among foreign customer groups, with coordinators/referrals providing information and coordination. The company has written agreements with coordinators/referrals but does not specify that they must exclusively refer customers to the company. Therefore, the company faces a risk of revenue dependency on referrals from these major coordinators/referrals.

However, these major coordinators/referrals have been in contact with the company since 2019 and have maintained a good relationship. The company has a policy of working with business partners with honesty and responsibility, along with maintaining the quality standards of its services. As a result, the company is confident that it will continue to receive cooperation in customer referrals from these coordinators/referrals.

The proportion of revenue that the Company received through coordinators/referrals in 2022, 2023 and 2024 were 93.46%, 76.61% and 84.78%, respectively.

The Company has recruited new customer coordinators/referrals to reduce the risk of relying on any one customer coordinator/referral and to increase opportunities to expand its customer base. As of the end of 2022, 2023, and 2024. The Company had 5, 15 , and 10 coordinators/referrals respectively. and there are more than 30 coordinators/referrals who have previously expressed their intention to work with the Company. In addition, the Company plans to expand its revenue base from direct customer contact by increasing marketing both domestically and internationally, such as marketing through the Company's online media and introducing additional services at the clinic to increase the proportion of revenue from direct customer contact.

733 · Description: Business operations of partners in the supply chain · Info category: STRATEGIC_RISK · 735 · Description: Reliance on large partners / distributors or few partners / distributors · Info category: STRATEGIC_RISK · 736 · Description: Damage to company image and reputation · Info category: STRATEGIC_RISK
The risks associated with compliance with laws, regulations, and standards related to business.

The company is obligated to comply with laws and obtain various licenses related to business operations. The company must obtain licenses from agencies such as the Ministry of Public Health, for example. The company must also adhere to the standards for providing services related to assisted reproductive technology in accordance with the Protection of Children Born from Assisted Reproductive Technologies Act B.E. 2558 (2015) and/or other government agencies responsible for overseeing licenses or other necessary standards of the company.

The company has complied with relevant laws and regulations and has obtained all relevant licenses and certificates for both infertility treatment services and preventive and restorative medicine services. Moreover, the company has appointed a person responsible for monitoring laws, regulations, and rules related to the business to ensure that the company is prepared to comply with such laws, regulations, and rules correctly and in a timely manner.

756 · Description: Change in laws and regulations · Info category: COMPLIANCE_RISK · 757 · Description: Laws and regulations is not favorable for doing business · Info category: COMPLIANCE_RISK · 758 · Description: Violations of laws and regulations · Info category: COMPLIANCE_RISK · 730 · Description: Government policy · Info category: STRATEGIC_RISK · 1718 · Description: Pandemic risk · Info category: STRATEGIC_RISK · 1722 · Description: Pandemic risk · Info category: OPERATIONAL_RISK
The risk of relying on skilled personnel.

In the company's business operations, it is necessary to have medical personnel with expertise in various fields, such as obstetricians, anesthesiologists, embryologists, genetic screening scientists, professional nurses, and preventive and restorative medicine specialists, to be able to provide comprehensive services to customers.

The service provided to each customer has a rather specific time frame. Therefore, if the company lacks personnel in any area and cannot find a replacement in a timely manner, it may not be possible to carry out the infertility treatment process on schedule.

The company has prepared a recruitment and personnel development process for replacements in each key position, such as training scientists in each field of work, as well as creating work manuals to enable personnel to perform their duties in accordance with standards. In addition, the company has opened for applications from physicians who wish to work with the company on a part-time basis to accommodate the increasing number of customers and as a risk prevention measure for the shortage of physicians. The company will manage appointments between clients and part-time physicians selected by the company to work with the company. Therefore, even if one person is unable to perform their duties, the company can continue to provide treatment. For the provision of rehabilitation medicine services, in the past, most of the customers who received services were customers who came to receive treatment for infertility. The company therefore assigned it to be under the care of the company's permanent physicians and has procured 1 part-time physician to provide services to the general public. In the future, if there are more customers using the service, the company will procure additional part-time physicians to provide rehabilitation medicine services. In addition, the company has retained personnel by establishing appropriate and fair compensation policies that allow personnel to receive appropriate compensation and benefits, along with promoting personnel development and instilling organizational culture, as well as creating incentives for personnel working with the company to understand the same vision and goals and be ready to jointly create sustainable growth together with the company.

738 · Description: Reliance on employees in key positions · Info category: OPERATIONAL_RISK · 756 · Description: Change in laws and regulations · Info category: COMPLIANCE_RISK · 739 · Description: Shortage or reliance on skilled workers · Info category: OPERATIONAL_RISK
The risk from competition in the industry.

The competition in providing infertility treatment services is likely to increase, primarily due to businesses in the same sector planning to continuously expand their branches. Additionally, the number of personnel involved in infertility treatment is rising, both from graduates and the development of staff in various establishments. Therefore, there is a possibility of new establishments being opened to support medical tourism in Thailand, which is being promoted by the government.

The competition in the field of regenerative medicine is also on the rise due to the promotion of health tourism policies by the government, leading to numerous operators in Thailand providing such services. In terms of plasma filtration services using special filters ("DFPP"), which is considered a core service in the current regenerative medicine business of the company, there are several hospitals and clinics offering healthcare services, including clinics providing aesthetic services.

The company recognizes the risks posed by competition in this industry, thus emphasizing the creation of brand awareness and the continuous improvement of quality to instill customer confidence in its services. The company is the first in the fertility treatment center business group in the Asia region to receive AACI and ISO9001:2015 certification, with AACI being the only international standard currently capable of certifying both International Healthcare Standard and ISO9001 simultaneously. Additionally, the company has been officially accredited by Global Healthcare Accreditation as the second in the world (specific program for Covid-19 for Medical Travel), demonstrating a quality management system for healthcare services under international standards. Furthermore, it has received accreditation for its reproductive medicine services from Temos International Healthcare Accreditation, a German healthcare accreditation body, in both Quality in reproductive care and Excellence in international reproductive care. Moreover, the company continues to introduce new services to customers to enhance opportunities for conception and assess embryo abnormalities. For example, the provision of preventive and rehabilitative medical services, as well as genetic testing using SNP array techniques, including the use of closed system embryo culture with AI systems for monitoring and scoring embryos, will instill confidence in clients regarding the company's services.

The use of strategies to create brand awareness and improve service quality to build customer confidence, similar to businesses that treat infertility, involves positioning in the market as a service provider for mid to high-end clients, located in the central business district of Bangkok, with decor that aligns with a high-end market image, including having foreign customer service representatives familiar with the target foreign clientele. The company believes that providing rehabilitation medicine services alongside infertility treatment will enhance its competitive potential in the rehabilitation medicine business, as it has a customer base that trusts its infertility treatment services, which is a significant primary customer base compared to operators that only provide rehabilitation medicine services.

756 · Description: Change in laws and regulations · Info category: COMPLIANCE_RISK · 733 · Description: Business operations of partners in the supply chain · Info category: STRATEGIC_RISK · 736 · Description: Damage to company image and reputation · Info category: STRATEGIC_RISK · 1714 · Description: Competition risk · Info category: STRATEGIC_RISK
Risks from Technological Changes and Treatment Approaches

Infertility treatment services are highly dependent on technology and medical advancements. This is evident in the development of assisted reproductive technology, which has progressed from GIFT to the present day, with ICSI being the method with the highest success rate.

In the future, there may be new treatment methods, which could be merely slight improvements to enhance current technology for a higher success rate in treatment, such as having more efficient and safer medical tools and equipment, among others. Alternatively, it could involve entirely new technologies or new treatment approaches.

The company has assigned personnel responsible for monitoring information and news, both in terms of technology and relevant academic articles, to keep abreast of medical and scientific advancements. The company also supports its personnel in attending medical conferences and seminars on related topics both domestically and internationally on a regular basis. In addition, the company is ready to invest in new technologies that will contribute to more efficient services, such as embryo chromosome screening using SNP Array techniques, 4D ultrasound, and healthcare with DFPP machines. Furthermore, the company has invested in a closed embryo culture system (Embryoscope Plus), which utilizes AI in embryo monitoring and grading, as well as investing in a semen analysis machine that uses AI in sperm selection and grading. The company will consider the benefits that service users will receive in conjunction with the economic value of the investment. Therefore, the company is confident that it is prepared for changes to accommodate both technological advancements and new treatment guidelines to be able to provide efficient services to customers at all times.

729 · Description: Behavior or needs of customers / consumers · Info category: STRATEGIC_RISK · 732 · Description: Changes in technologies · Info category: STRATEGIC_RISK · 742 · Description: Human error in business operations · Info category: OPERATIONAL_RISK
The risk of relying on pharmaceutical and medical supply distributors.

Some drugs or medical supplies have only one distributor representing the foreign manufacturer, such as reagents specifically used for preimplantation genetic testing for aneuploidy (PGT-A) using SNP Array, a technology exclusive to a particular foreign operator. This also includes drugs or medical supplies with specific properties required by physicians or scientists, where the procurement of such products must be ordered from specific distributors.

If the company is unable to procure the said products in the required quantity or timeframe, it may impact customer service.

In order to reduce the risk of reliance on specific suppliers, the company has compiled a list of alternative suppliers for products that can replace those currently used in its services and is monitoring new substitute products that may emerge as options for the company. For products for which substitutes cannot be found, the company has closely coordinated with product distributors and designated responsible parties to ensure that inventory levels are sufficient and not excessive.

756 · Description: Change in laws and regulations · Info category: COMPLIANCE_RISK · 730 · Description: Government policy · Info category: STRATEGIC_RISK · 740 · Description: Shortage or fluctuation in pricing of raw materials or productive resources · Info category: OPERATIONAL_RISK · 743 · Description: Product obsolescence · Info category: OPERATIONAL_RISK · 735 · Description: Reliance on large partners / distributors or few partners / distributors · Info category: STRATEGIC_RISK · 1721 · Description: Inventory risk · Info category: OPERATIONAL_RISK
The risk of being sued for damages arising from medical services.

The provision of medical services, including infertility treatment and plasma filtration using special filters, is considered a medical service for which success cannot be guaranteed every time.

There is a possibility that the patient may be dissatisfied with the services provided by the company, or in cases where the patient experiences complications during the service or any abnormalities that are expected to arise from the company's services, which may lead to legal action for damages due to medical services. Therefore, the company is at risk of being affected in terms of its image and reputation, and this may impact the company's performance in the event of a damage claim.

The company therefore pays attention to service quality with AACI, ISO9001:2015, GHA, and Temos standards, and places importance on customer satisfaction from the process of selecting doctors, embryologists, genetic screening scientists, nursing teams, and experienced customer care staff who are skilled and have been in the industry for a long time. The company's customer service representatives possess coordination skills and are capable of communicating in multiple languages to provide comprehensive advice and inform about various service details, including risks that may not meet expectations from the service received. The company has procedures in place to explain both verbally and to have service users sign a consent form for treatment at every step according to the regulations of the Medical Council. The consent form will detail the possible causes of infertility, treatment procedures, success rates, and potential risks, so that the recipient understands the process, risks, and chances of success of the treatment. For plasma filtering services using special filters, it must be under the supervision of a physician to assess the suitability for the service and closely monitor complications during the service, especially in those with pre-existing conditions.

The customer service representatives will follow up to coordinate and assess the satisfaction of service recipients throughout the service process. In cases where service recipients may be dissatisfied or misunderstand the company's services, the customer service representatives will report to the management for consideration of actions according to the company's established measures for handling such situations. Additionally, the company has a professional insurance policy for both full-time and part-time doctors.

Throughout the past period, the company has never had any disputes or been sued for damages arising from its services.

729 · Description: Behavior or needs of customers / consumers · Info category: STRATEGIC_RISK · 742 · Description: Human error in business operations · Info category: OPERATIONAL_RISK · 1723 · Description: Legal risk · Info category: COMPLIANCE_RISK · 736 · Description: Damage to company image and reputation · Info category: STRATEGIC_RISK
The risk of withholding tax submission in cases where the Revenue Department assesses the personal income tax of the physician differently from the company's guidelines.

The company is seeking to hire physicians who wish to work temporarily (Part Time) to provide additional services to customers. In order to remit taxes to the Revenue Department accurately and completely, the company will withhold taxes at source according to the type of employment, which includes permanent employee contracts and contract-based hiring. However, the considerations according to the Revenue Department's practices regarding the taxation of physicians may differ from the company's withholding taxes for remittance to the Revenue Department.

Therefore, the company is at risk of remitting withholding tax that is not equal to the actual amount due.

To mitigate the impact of future tax risk factors, the company has established a written agreement with part-time personnel, stipulating that such personnel acknowledge and agree to be responsible for any expenses that may arise from additional tax assessments that may occur to the company as a result of withholding tax on each individual personnel, in order to prevent potential impacts on the company from such cases.

756 · Description: Change in laws and regulations · Info category: COMPLIANCE_RISK · 758 · Description: Violations of laws and regulations · Info category: COMPLIANCE_RISK · 730 · Description: Government policy · Info category: STRATEGIC_RISK
Risks from the impact of the Coronavirus Disease 2019 (COVID-19) pandemic or other pandemics

In the initial phase of service, the company's primary customer base consisted of foreigners. Therefore, when the severe outbreak of the Coronavirus disease 2019 (COVID-19) pandemic occurred from 2020 to 2021, it significantly impacted the company. This situation resulted in foreign customers being unable to travel and utilize the company's services. Consequently, the company's operational performance in 2020 and 2021 experienced losses.

The company is therefore at risk of being impacted in its operations in the event of the spread of COVID-19 or any other epidemic that results in limitations to the company's service provisions.

The company was able to manage its business operations during the COVID-19 pandemic by adjusting its target customer base, focusing on domestic customers during 2020-2021. During this period, the company also used the time to develop service quality standards to build confidence among users. The company was officially accredited by Global Healthcare Accreditation (COVID-19-specific program for Medical Travel), which is a standard for patients traveling for medical treatment, and received the AACI accreditation, which is used for healthcare organization certification processes, as well as the ISO 9001:2015 quality management system certification in 2021. Additionally, the company adjusted its marketing channels by increasing online media presence to raise awareness of its services among domestic customers and to maintain communication with international clients who could not travel to the country. The company paid great attention to service and safety from COVID-19, including temperature checks before service, health history inquiries, and tests before service, maintaining social distancing, and requiring patients to wear

masks at all times during service.

Although the impact of the COVID-19 pandemic has decreased and foreign customers are now able to travel to use the company's services, the company will continue to monitor news and information regarding other potential pandemics or outbreaks that could affect its business operations. This will enable the company to plan and manage risks and minimize any potential future impacts on the business. Additionally, the company has plans to invest or co-invest in expanding branches or increasing service points in foreign countries, which will help reduce such risks.

756 · Description: Change in laws and regulations · Info category: COMPLIANCE_RISK · 1725 · Description: Income volatility · Info category: FINANCIAL_RISK · 749 · Description: Safety, occupational health, and working environment · Info category: OPERATIONAL_RISK · 1718 · Description: Pandemic risk · Info category: STRATEGIC_RISK · 1722 · Description: Pandemic risk · Info category: OPERATIONAL_RISK
Risks of Lease Extension

The company's service location consists of a customer reception area, examination rooms, operating rooms, an embryo lab, and a genetic lab. Currently, the company operates at one location in the Ploenchit Center building, where the Prime Office Real Estate Investment Trust ("REIT") holds the land lease rights for the building. The company's current lease agreement will expire on June 30, 2030. However, the land lease agreement between the REIT and the landowner will expire on January 23, 2025, which is earlier than the expiration of the company's current lease agreement.

Therefore, the company faces the risk of having to find a new business location if the lease agreement is not renewed. This could result in the company being unable to provide services continuously for a period of time, unless proper advance management and planning have been made.

The REIT and the landowner have signed a notice of transfer of lease rights and building services for Ploenchit Center with the company, informing the transfer of all rights and obligations of the REIT as the lessor and service provider to the landowner once the REIT’s land lease expires. Therefore, the company has the right to lease the space until the lease expires on June 30, 2030. The current lease agreement includes provisions that allow the tenant to express their intention to extend the lease. Additionally, the contract specifies that the company must notify the lessor of its intention to extend at least 180 days before the lease term ends. The lessor is required to notify the tenant of the lease extension decision within 90 days of the notice, which provides the company with enough time to manage and ensure that its services can continue without interruption. Furthermore, the landowner has provided a letter confirming the intended use of the Ploenchit Center building as an office building and agrees to allow the company to lease the space for its business operations until 2034. The company has consistently complied with the lease conditions and has successfully renewed the lease in the past. Therefore, the company is confident that it will continue to receive lease extensions in the future.

However, the company has plans to invest or co-invest in expanding branches or increasing service points both domestically and internationally. This strategy will help mitigate the risk of relying on a single location in the future.

748 · Description: Property lease agreement execution · Info category: OPERATIONAL_RISK
The risk of relying on executives.

The current chief executive officer of the company is Ms. Kasinee Kuladiloke, who holds the position of executive director and chief executive officer. She has extensive experience in business and company management since the early stages and has a vision along with direct responsibilities in determining the company's policies, direction, and operations.

If there is a change in the management in the position and a suitable new executive cannot be recruited to replace him. This may result in problems in business operations in the future.

The company supports executives in receiving training in various fields to enhance their knowledge and skills and to develop continuously. Additionally, the Board of Directors has established a succession plan and talent management policy to guide the recruitment and development of personnel, as well as to ensure that the company is prepared to operate its business continuously in the long term. This is to ensure that executives in all positions have sufficient knowledge and skills to take over the business from senior executives and to reduce the risk of relying on any one executive for the company's management.

738 · Description: Reliance on employees in key positions · Info category: OPERATIONAL_RISK · 739 · Description: Shortage or reliance on skilled workers · Info category: OPERATIONAL_RISK
The risk that major shareholders have influence over the determination of management policies.

The group of Mr. Chanachai Joonjiraporn, which includes Mr. Chanachai Joonjiraporn and Ms. Kasinee Kuladiloke, are the major shareholders of the company, holding approximately 42.23% of the paid-up capital collectively. This group of shareholders also serves as the management and authorized signatories of the company, thus granting them the authority to manage and the ability to oppose any resolutions that require a three-fourths majority of the shares present at the meeting as stipulated by law or the company's regulations. Therefore, other shareholders of the company may face risks due to their inability to gather sufficient votes to balance matters proposed by the major shareholders.

Other shareholders of the company may be at risk of being unable to gather votes to balance the matters proposed by major shareholders.

In order to ensure that business operations are conducted transparently, fairly, and in accordance with good corporate governance principles, the company has established a management structure comprising knowledgeable and capable personnel, and has clearly defined the scope of authority and responsibilities. Additionally, a remuneration and nomination committee has been formed as an important tool or mechanism for selecting individuals with potential to support growth and adapt to changing business circumstances. Furthermore, an audit committee has been appointed, consisting of three independent directors with no vested interests in the company, to oversee the company's operations and adequately safeguard the interests of minority shareholders, thereby creating a balanced power structure in management at an appropriate and auditable level.

738 · Description: Reliance on employees in key positions · Info category: OPERATIONAL_RISK · 759 · Description: Corporate Governance · Info category: COMPLIANCE_RISK · 1741 · Description: Corporate ownership structure risk · Info category: STRATEGIC_RISK

Risks to Securities Holders' Investment

Risk Register

Risk NameRisk CharacteristicsConsequencesRelated Risk Factors
The risk from the volatility of the common stock prices of the company after entering into trading on the Stock Exchange of Thailand.

The price of the Company’s common shares may tend to fluctuate or change according to market trading conditions or may result from other factors beyond the Company’s control, such as:

• Changes in global, regional, and domestic economic, capital market, and political conditions.

• General stock market conditions, including stock price volatility in the Stock Exchange.

• Perceptions of opportunities for the Company’s business and operations, including general industry conditions.

• Volatility in the Company’s actual or anticipated operating results.

• The difference between actual financial performance and operating results and the financial performance and operating results expected by investors and analysts.

• Analysts’ recommendations or views on the Company’s securities or the Company’s industry.

• Changes in the operating results and share prices of listed companies in similar businesses to the Company.

• The liquidity of the Company’s shares traded on the Stock Exchange.

• Changes in relevant laws and regulations.

• Changes in various conditions affecting the industries related to the Company.

• Changes in tax and monetary policies, and

• Volatility in interest rates and market prices of debt and equity instruments.

The market price of the Company's ordinary shares and the demand for the Company's shares have been volatile, which may result in the trading price of the Company's shares on the Stock Exchange of Thailand being significantly lower than the offering price of the ordinary shares in this offering. This may also result in restrictions or impediments to the ability of investors to sell the Company's ordinary shares and may have a negative impact on the liquidity of the Company's shares.

769 · Other name: Price volatility · Description: Other · Info category: HOLDER_RISK
The risk to existing shareholders residing outside of Thailand arising from the Company's potential inability to offer newly issued securities in future transactions to such shareholders on a pro rata basis (Rights Offering).

In the event that the Company offers newly issued securities or grants any other rights to existing shareholders, such as warrants, transferable subscription rights (TSR), and convertible debentures, the Company has the discretion not to offer or grant the right to subscribe for newly issued securities to existing shareholders residing outside of Thailand. The Company may also be restricted by the provisions of certain countries' laws that prohibit the Company from offering or granting the right to subscribe for newly issued securities to shareholders in those countries. For example, the Company may not offer or grant the right to subscribe for newly issued securities to U.S. Persons unless (a) the Company has filed a registration statement under the securities laws of the United States, or (b) the offering of newly issued securities is exempt from registration under the securities laws of the United States.

Compliance with securities laws or other regulatory provisions in certain countries may restrict some investors from subscribing to newly issued securities that the Company offers to existing shareholders on a pro rata basis, and may result in a dilution of the shareholding of such investors. Furthermore, the Company is not obligated to file for registration of its securities in any other country or jurisdiction outside of Thailand to allow foreign investors the right to subscribe to newly issued securities offered to existing shareholders on a pro rata basis.

769 · Other name: The risk to existing shareholders residing outside of Thailand arising from the Company's potential inability to offer newly issued securities in future rights offerings to such shareholders in proportion to their existing shareholdings. · Description: Other · Info category: HOLDER_RISK
Risk of major shareholders selling ordinary shares after the initial public offering

After this public offering and the listing of the ordinary shares on the Stock Exchange of Thailand, the company expects to have a total of 130.00 million shares, representing 29.55 percent of the total number of issued and sold shares of the company, which can be freely traded on the Stock Exchange of Thailand.

According to the Stock Exchange of Thailand's regulations on the Listing of Securities, Disclosure of Information, and Delisting of Securities on the "Market for Alternative Investment", the shares of those involved in the management of the company, such as major shareholders, directors, and executives, shall be prohibited from selling their ordinary shares, which amount to 55.00 percent of the total number of issued and sold shares of the company after the public offering of newly issued ordinary shares, for a period of 1 year from the date the company's ordinary shares commence trading on the Stock Exchange of Thailand. However, the restricted persons may gradually sell such ordinary shares in the amount of 25.00 percent of the restricted shares upon the expiration of a period of 6 months and may sell the remaining 75.00 percent of the restricted shares after the expiration of a period of 1 year from the date the company's ordinary shares commence trading on the Stock Exchange of Thailand.

The sale of a significant number of the company's common shares in the Stock Exchange of Thailand following this offering of common shares, or the anticipation of such a sale, may negatively impact the market price of the company's common shares and could result in significant losses for investors who purchase the company's common shares in this public offering. Furthermore, the company may undergo changes in its management structure in accordance with the investment policies of new investors. However, such structural changes will prioritize the best interests of the company, and any changes to the board of directors and/or the addition of directors, executives, or personnel must be conducted in compliance with the relevant regulations.

2970 · Description: Risk of the company having a majority shareholder holding > 25% of shares · Info category: HOLDER_RISK
Contents